Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  1,786 نتائج ل ""Neuromuscular Agents""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.

  • Authors : Choi SY; Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si, Gyeonggi-do, Republic of Korea.; Koh YG

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/adverse effects ; Skin Aging*/Skin Aging*/Skin Aging*/drug effects

  • Source: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2359511. Date of Electronic Publication: 2024 Jun 16.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Are We Missing Something About the Maximum Dosing of Botulinum Toxin Type A1 in Adult and Pediatric Patients with Spasticity?

  • Authors : Picelli A; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.; Department of Neurosciences, University Hospital of Verona, 37126 Verona, Italy.

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Muscle Spasticity*/Muscle Spasticity*/Muscle Spasticity*/drug therapy

  • Source: Toxins [Toxins (Basel)] 2024 Nov 27; Vol. 16 (12). Date of Electronic Publication: 2024 Nov 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Complete Improvement of Severe Forearm Complex Regional Pain Syndrome with Six High-Dose Incobotulinumtoxin A Injections: Clinical Implications with Respect to the Literature.

  • Authors : Hefter H; Department of Neurology, University of Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.; Moll M

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Forearm*

  • Source: Toxins [Toxins (Basel)] 2024 Nov 10; Vol. 16 (11). Date of Electronic Publication: 2024 Nov 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Novel single-entry point injection technique for masseter hypertrophy treatment using botulinum neurotoxin based on patient-reported comfort.

  • Authors : Wan J; Asia Pacific Aesthetic Academy, Hong Kong, Hong Kong.; Kim JS

Subjects: Masseter Muscle*/Masseter Muscle*/Masseter Muscle*/drug effects ; Masseter Muscle*/Masseter Muscle*/Masseter Muscle*/abnormalities ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage Masticatory Muscles, Hypertrophy of

  • Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Nov; Vol. 23 (11), pp. 3539-3543. Date of Electronic Publication: 2024 Jul 15.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Treatment of masseter muscle hypertrophy with botulinum toxin type A injection: A review of adverse events.

  • Authors : Nishikawa A; Cosmetic Dermatology, SBC Medical Group, Medical Corporation Shoubikai, Tokyo, Japan.; Aikawa Y

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/adverse effects ; Masseter Muscle*/Masseter Muscle*/Masseter Muscle*/drug effects Masticatory Muscles, Hypertrophy of

  • Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Nov; Vol. 23 (11), pp. 3544-3550. Date of Electronic Publication: 2024 Jul 12.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The Lack of Effect of Botulinum Toxin-A on Upper Limb Activity in Chronic Stroke: A Short Report from the InTENSE Trial.

  • Authors : Cameron ID; John Walsh Centre for Rehabilitation Research, Northern Sydney Local Health District, St Leonards, NSW 2065, Australia.; Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia.

Subjects: Stroke*/Stroke*/Stroke*/drug therapy ; Stroke*/Stroke*/Stroke*/physiopathology ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use

  • Source: Toxins [Toxins (Basel)] 2024 Nov 26; Vol. 16 (12). Date of Electronic Publication: 2024 Nov 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Does the Diffusion Profile Differ Between Botulinum Toxin Type a Formulations? Implications for the Management of Post-Stroke Spasticity.

  • Authors : Picelli A; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.; Department of Neurosciences, University Hospital of Verona, 37126 Verona, Italy.

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Muscle Spasticity*/Muscle Spasticity*/Muscle Spasticity*/drug therapy

  • Source: Toxins [Toxins (Basel)] 2024 Nov 07; Vol. 16 (11). Date of Electronic Publication: 2024 Nov 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Does botulinum neurotoxin A make walking easier in children with cerebral palsy? A randomized clinical trial.

Subjects: Cerebral Palsy*/Cerebral Palsy*/Cerebral Palsy*/drug therapy ; Cerebral Palsy*/Cerebral Palsy*/Cerebral Palsy*/physiopathology ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage

  • Source: Developmental medicine and child neurology [Dev Med Child Neurol] 2025 Feb; Vol. 67 (2), pp. 263-271. Date of Electronic Publication: 2024 Jul 26.Publisher: Blackwell Country of Publication: England NLM ID: 0006761 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-8749

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy and safety of botulinum neurotoxin in the treatment of hemifacial spasms: a systematic review and meta-analysis.

  • Authors : Wang B; Jilin Province Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, 130021, China.; Department of Orthodontics, Hospital of Stomatology, Jilin University, Changchun, 130021, China.

Subjects: Botulinum Toxins*/Botulinum Toxins*/Botulinum Toxins*/administration & dosage ; Botulinum Toxins*/Botulinum Toxins*/Botulinum Toxins*/adverse effects ; Hemifacial Spasm*/Hemifacial Spasm*/Hemifacial Spasm*/drug therapy

  • Source: BMC neurology [BMC Neurol] 2024 Oct 29; Vol. 24 (1), pp. 420. Date of Electronic Publication: 2024 Oct 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information.

  • Authors : Dashtipour K; Department of Neurology/Movement Disorders, Loma Linda University, Loma Linda, CA 92354, USA.; Lee HS

Subjects: Torticollis*/Torticollis*/Torticollis*/drug therapy ; Muscle Weakness*/Muscle Weakness*/Muscle Weakness*/chemically induced ; Muscle Weakness*/Muscle Weakness*/Muscle Weakness*/drug therapy

  • Source: Toxins [Toxins (Basel)] 2024 Oct 15; Vol. 16 (10). Date of Electronic Publication: 2024 Oct 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  1,786 نتائج ل ""Neuromuscular Agents""